Clinical Trials Directory

Trials / Unknown

UnknownNCT01472120

Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD)

The Relationship of Adiponectin With Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
160 (estimated)
Sponsor
Gulhane School of Medicine · Academic / Other
Sex
Male
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

In peripheral blood; monocytes and macrophages are found in two phenotype; proinflammatory M1 and anti-inflammatory M2 phenotypes. M2 form is converted (or polarized) to M1 phenotype in various metabolic disorders such as obesity and type 2 diabetes mellitus.

Detailed description

In peripheral blood; monocytes and macrophages are found in two phenotype; proinflammatory M1 and anti-inflammatory M2 phenotypes. M2 form is converted (or polarized) to M1 phenotype in various metabolic disorders such as obesity and type 2 diabetes mellitus. In addition, these forms also are related to insulin resistance and inflammation in adipose tissue. Today, there is no study that investigate the role of adiponectin an anti-inflammatory adipokine, on macrophage polarization in non-alcoholic fatty liver disease.

Conditions

Timeline

Start date
2011-12-01
Primary completion
2012-09-01
Completion
2013-01-01
First posted
2011-11-16
Last updated
2011-11-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01472120. Inclusion in this directory is not an endorsement.

Adiponectin and Circulating Macrophage Phenotypes in Non-alcoholic Fatty Liver Disease (NAFLD) (NCT01472120) · Clinical Trials Directory